401895-68-9 Usage
General Description
1-(3-(4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)phenoxy)propyl)piperidine is a chemical compound that consists of a piperidine ring attached to a phenoxy group, which in turn is linked to a boron-containing group. The boron-containing group in this compound is 4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl, and it is attached to the phenoxy group through a propyl chain. 1-(3-(4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)phenoxy)propyl)piperidine is used in various research and industrial applications, including as a building block in organic synthesis and as a precursor in the production of pharmaceuticals and agrochemicals. It may also have potential uses in materials science and catalysis due to its boron-containing group.
Check Digit Verification of cas no
The CAS Registry Mumber 401895-68-9 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 4,0,1,8,9 and 5 respectively; the second part has 2 digits, 6 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 401895-68:
(8*4)+(7*0)+(6*1)+(5*8)+(4*9)+(3*5)+(2*6)+(1*8)=149
149 % 10 = 9
So 401895-68-9 is a valid CAS Registry Number.
401895-68-9Relevant articles and documents
1,3-DIHYDROIMIDAZO[4,5-C]CINNOLIN-2-ONE COMPOUNDS AND THEIR USE IN TREATING CANCER
-
Page/Page column 67; 68, (2019/04/16)
The specification generally relates to compounds of Formula (I) and pharmaceutically acceptable salts thereof, where R1-R4, A and X have the meanings defined herein. The specification also relates to the use of compounds of Formula (I) and salts thereof to treat or prevent ATM mediated disease, including cancer. The specification further relates to pharmaceutical compositions comprising substituted 1,3-dihydroimidazo[4,5-c]cinnolin-2-one compounds and pharmaceutically acceptable salts thereof; and kits comprising such compounds and salts.